← Eichor
Study identifier: NCT07488091 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multi Disciplinary Sickle Cell Disease Obstetrics Care Program in Ghana

Condition: Sickle Cell Disease and Pregnancy  ·  Sponsor: University of Ghana Medical School

PhaseNA
Planned participants198
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this observational study is to determine the feasibility and effectiveness of initiating a multidisciplinary sickle cell disease (SCD) obstetrics program for women with SCD in a non-academic hospital. The main question it aims to answer is: In a before-and-after study design, we will test the hypothesis that multidisciplinary care for pregnant women with SCD in a non-academic hospital will result in a 50% relative risk reduction in mortality compared to the mortality rate in pregnant women with SCD in the same hospital before the multidisciplinary care. Participants will be managed using the academic hospital's multidisciplinary sickle cell disease obstetrics protocol adapted for the non-academic hospital

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Eugenia Vicky N. K. Asare, Senior Specialist Hematologist, MBChB  ·  +233 542354386 / 233 302660762  ·  evnkasare@ug.edu.gh

Always discuss trial participation with your own doctor first.

Locations (1)

Greater Accra Regional HospitalAccra, GhanaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07488091